These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
743 related items for PubMed ID: 18266826
1. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children. Bernsen RM, van der Wouden JC. Pediatr Allergy Immunol; 2008 Sep; 19(6):544-51. PubMed ID: 18266826 [Abstract] [Full Text] [Related]
2. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Roost HP, Gassner M, Grize L, Wüthrich B, Sennhauser FH, Varonier HS, Zimmermann H, Braun-Fahrländer Ch, SCARPOL-team. Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514 [Abstract] [Full Text] [Related]
3. Reported pertussis infection and risk of atopy in 8- to 12-yr-old vaccinated and non-vaccinated children. Bernsen RM, Nagelkerke NJ, Thijs C, van der Wouden JC. Pediatr Allergy Immunol; 2008 Feb; 19(1):46-52. PubMed ID: 18086216 [Abstract] [Full Text] [Related]
4. Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Alfredsson R, Svensson E, Trollfors B, Borres MP. Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890 [Abstract] [Full Text] [Related]
5. Acute infections, infection pressure, and atopy. Paunio M, Peltola H, Virtanen M, Leinikki P, Makela A, Heinonen OP. Clin Exp Allergy; 2006 May; 36(5):634-9. PubMed ID: 16650049 [Abstract] [Full Text] [Related]
6. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia. Jaber SM. Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596 [Abstract] [Full Text] [Related]
7. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Mrozek-Budzyn D, Kiełtyka A, Majewska R. Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979 [Abstract] [Full Text] [Related]
8. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid]. Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A. An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183 [Abstract] [Full Text] [Related]
9. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Olesen AB, Juul S, Thestrup-Pedersen K. Acta Derm Venereol; 2003 May; 83(6):445-50. PubMed ID: 14690341 [Abstract] [Full Text] [Related]
10. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T, Baer M, Willems P. Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879 [Abstract] [Full Text] [Related]
12. Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8-12-year-old children. Bernsen RM, de Jongste JC, Koes BW, Aardoom HA, van der Wouden JC. Vaccine; 2006 Mar 15; 24(12):2035-42. PubMed ID: 16368169 [Abstract] [Full Text] [Related]
13. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C. Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798 [Abstract] [Full Text] [Related]
14. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 10; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related]
15. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. Clin Immunol; 2005 May 10; 115(2):154-61. PubMed ID: 15885638 [Abstract] [Full Text] [Related]
16. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM. Ann Rheum Dis; 2012 Jun 10; 71(6):948-54. PubMed ID: 22172491 [Abstract] [Full Text] [Related]
17. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad. Pediatr Infect Dis J; 2006 Jul 10; 25(7):615-22. PubMed ID: 16804432 [Abstract] [Full Text] [Related]
18. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis. Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE. Adv Perit Dial; 1999 Jul 10; 15():269-72. PubMed ID: 10682116 [Abstract] [Full Text] [Related]
19. An epidemiological study on Japanese autism concerning routine childhood immunization history. Takahashi H, Suzumura S, Shirakizawa F, Wada N, Tanaka-Taya K, Arai S, Okabe N, Ichikawa H, Sato T. Jpn J Infect Dis; 2003 Jun 10; 56(3):114-7. PubMed ID: 12944678 [Abstract] [Full Text] [Related]
20. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Bone Marrow Transplant; 2004 Jun 10; 33(12):1187-90. PubMed ID: 15077129 [Abstract] [Full Text] [Related] Page: [Next] [New Search]